| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |